BABA
Alibaba Group Holding Limited
BABA's outlook is improving, though it still trails on the overall score.
CCK
Crown Holdings, Inc.
CCK has the edge over BABA overall, supported by stronger fundamentals and stronger valuation.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
CCK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Stable |
CCK's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
CCK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $120 | — |
| Cheap | 16x | $118 | -2.4% |
| Current | 17x | $120 | — |
| Fair | 21x | $149 | +24% |
| Expensive | 25x | $178 | +48% |
Historical ranges are pointers, not guarantees.
CCK has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over CCK on the outlook, with more favorable profitability expectations.
CCK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CCK, with profitability holding steady.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
CCK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.74 | +22% |
| Q3 2026 | $7.19 | -11% |
| Q2 2026 | $6.96 | +47% |
| Q1 2026 | $6.29 | +36% |
| Q4 2025 | $6.38 | +80% |
| Q3 2025 | $8.07 | +896% |
| Q2 2025 | $4.75 | +32% |
| Q1 2025 | $4.64 | +34% |
| Q4 2024 | $3.55 | -5.6% |
CCK has the edge over BABA on earnings, with more consistent year-over-year improvement.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
CCK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +16% |
| Q2 2026 | $3.7B | +16% |
| Q1 2026 | $3.3B | +13% |
| Q4 2025 | $3.1B | +7.7% |
| Q3 2025 | $3.2B | +4.2% |
| Q2 2025 | $3.1B | +3.6% |
| Q1 2025 | $2.9B | +3.7% |
| Q4 2024 | $2.9B | +1.6% |
CCK has the edge over BABA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | -1.3 points |
| Q2 2026 | 13% | +0.2 points |
| Q1 2026 | 11% | -1.4 points |
| Q4 2025 | 12% | -0.1 points |
| Q3 2025 | 13% | -1.2 points |
| Q2 2025 | 12% | -0.1 points |
| Q1 2025 | 13% | +3.8 points |
| Q4 2024 | 12% | +3 points |
CCK has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
CCK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $299M | -39% |
| Q2 2026 | $597M | +52% |
| Q1 2026 | -$141M | -$122M |
| Q4 2025 | $255M | +75% |
| Q3 2025 | $488M | +2.1% |
| Q2 2025 | $393M | +8.9% |
| Q1 2025 | -$19M | +$177M |
| Q4 2024 | $146M | -67% |
CCK has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
CCK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -1.5M shares |
| 1 year | -6.4% | -7.4M shares |
| 3 years | -9.5% | -11.4M shares |
| 5 years | -16% | -21.4M shares |
| Available history | -20% | -26.9M shares |
CCK has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $81M |
| Q2 2026 | $305M |
| Q1 2026 | $212M |
| Q4 2025 | $191M |
| Q3 2025 | $105M |
| Q2 2025 | $6M |
| Q1 2025 | $203M |
| Q4 2024 | $100M |
CCK spent $789M buying back its own shares over the past year, up 91% from the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over CCK on leverage, with a lower net debt burden relative to earnings.
CCK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.5x | Moderate |
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 2.8x | Moderate |
| Q4 2025 | 2.6x | Moderate |
CCK's net debt is about 2.5 years of its operating earnings (EBITDA).
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
CCK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.6 | Neutral |
| Stochastic | 77.9 | Neutral |
CCK's weekly RSI is 63 (neutral) and its Stochastic is 78 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
CCK PE vs Consumer Cyclical Sector
| Metric | CCK | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7% below |
| PE % | 19 | 47 | 28 pts below |
CCK has the edge over BABA on valuation relative to its sector.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
CCK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $114.4 | 5.4% above |
| 20 week MA | $115.4 | 4.4% above |
| 50 week MA | $108.1 | 11% above |
| 100 week MA | $101.1 | 19% above |
| 200 week MA | $93.1 | 29% above |
CCK has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
CCK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $73.2 | $98.6 | +35% |
| 2021 | $98.6 | $105.7 | +7.2% |
| 2022 | $105.7 | $82.6 | -22% |
| 2023 | $82.6 | $92.1 | +12% |
| 2024 | $92.1 | $83.2 | -9.7% |
| 2025 | $83.2 | $102.9 | +24% |
| 2026 YTD | $102.9 | $120.5 | +17% |
CCK has the edge over BABA on returns for 2026, with the stronger performance.